| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/22/2004 | US20040076634 An envelope protein, antigens, consisting of amino acid sequances from virus, more potent, protecting from T helper and B cell immunity |
| 04/22/2004 | US20040076632 DNA vaccine against feline immunodeficiency virus |
| 04/22/2004 | US20040076629 Polypeptide with 46 kDalton HMFG differentiation antigen binding specificity and clotting factors V and VIII light-chain homologies, fusion protein, polynucleotide and polyribonucleotide encoding the polypeptide, anti-polypeptide antibodies, kits and methods of use thereof |
| 04/22/2004 | US20040076628 Use of IL-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 04/22/2004 | US20040076627 Humanised antibodies |
| 04/22/2004 | US20040076625 A fusion proteins comprising self or non-self antigens, is used for treatment and prevention of immunoglobulin E related diseases, gene expression |
| 04/22/2004 | US20040076611 Molecular antigen arrays |
| 04/22/2004 | US20040076608 Cytokine uses; compositions; methods |
| 04/22/2004 | US20040076607 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/22/2004 | US20040076606 Methods of modulating inflammation by administration of interleukin-19 and inhibitors of IL-19 binding |
| 04/22/2004 | DE10248123A1 Preparation of properly folded ion channels, useful e.g. for identifying specific ligands, by dissolving recombinant subunits in first detergent solution then exchange to second detergent to induce folding |
| 04/22/2004 | DE10247755A1 New fusion polypeptide, useful for treating e.g. cancer, infections and inflammation, comprises binding domain for cell-surface molecule and fragment of tumor necrosis factor ligand |
| 04/22/2004 | DE10247014A1 New multimer of major histocompatibility complex molecules, useful e.g. for sorting specific T cells for therapeutic application, includes a chromoprotein as multimerizing agent |
| 04/22/2004 | CA2823937A1 Hiv vaccine formulations |
| 04/22/2004 | CA2820949A1 Novel immunogenic proteins of leptospira |
| 04/22/2004 | CA2501939A1 Novel immunogenic proteins of leptospira |
| 04/22/2004 | CA2501913A1 Isolated mammalian membrane protein genes; related reagents |
| 04/22/2004 | CA2501879A1 Promoter to il-18bp, its preparation and use |
| 04/22/2004 | CA2501875A1 Cap-binding protein |
| 04/22/2004 | CA2501873A1 A method for diagnosis and prognosis of multiple sclerosis |
| 04/22/2004 | CA2501872A1 Screening systems and methods for identifying modulators of xenobiotic metabolism |
| 04/22/2004 | CA2501870A1 Single chain recombinant t cell receptors |
| 04/22/2004 | CA2501855A1 Nucleic acids encoding duramycin |
| 04/22/2004 | CA2501851A1 Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 04/22/2004 | CA2501832A1 Erythropoietin: remodeling and glycoconjugation of erythropoietin |
| 04/22/2004 | CA2501635A1 Method of purifying lantibiotics |
| 04/22/2004 | CA2501630A1 Stem cell expansion factor blocking a gene limiting hox-induced expansion and method using such factor |
| 04/22/2004 | CA2501602A1 Novel tumor suppressor gene and compositions and methods for making and using the same |
| 04/22/2004 | CA2501577A1 Heat shock protein binding fragments of cd91, and uses thereof |
| 04/22/2004 | CA2501476A1 Hiv vaccine formulations |
| 04/22/2004 | CA2501459A1 Production of homotrimeric fusion proteins |
| 04/22/2004 | CA2501445A1 Polypeptides involved in spiramycin biosynthesis, nucleotide sequences encoding said polypeptides and uses thereof |
| 04/22/2004 | CA2501289A1 Novel full-length genomic rna of japanese encephalitis virus, infectious jev cdna therefrom, and use thereof |
| 04/22/2004 | CA2501238A1 Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using |
| 04/22/2004 | CA2501233A1 Assay methods for state-dependent calcium channel agonists/antagonists |
| 04/22/2004 | CA2501057A1 Igf-binding protein-derived peptide or small molecule |
| 04/22/2004 | CA2500772A1 Uses of human zven antagonists |
| 04/22/2004 | CA2500741A1 Glucose transport mutants for production of biomaterial |
| 04/22/2004 | CA2500665A1 Methods of regulating body weight |
| 04/22/2004 | CA2499896A1 Hepatocyte growth factor variants |
| 04/22/2004 | CA2487854A1 Method for screening an agent for treating renal failure |
| 04/21/2004 | EP1411127A1 Transgenic zoysiagrass with reduced shade avoidance |
| 04/21/2004 | EP1411124A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 04/21/2004 | EP1411121A1 Dna fragments containing gene having function relating to autonomous proliferation of plasmid |
| 04/21/2004 | EP1411063A1 Peptide nucleic acids |
| 04/21/2004 | EP1410807A1 Methods and compositions useful for inhibition of angiogenesis |
| 04/21/2004 | EP1410804A1 Cancer vaccine containing cancer antigen based on tumor suppressor gene wt1 product and cationic liposomes |
| 04/21/2004 | EP1410803A1 MIA-2 proteins |
| 04/21/2004 | EP1410802A1 Cell death inducers for mast cells |
| 04/21/2004 | EP1410038A2 Assays for identifying modulators of rhomboid polypeptides |
| 04/21/2004 | EP1410019A1 Cardiovascular safety assay |
| 04/21/2004 | EP1410018A1 Method for detecting modultators of notch signalling |
| 04/21/2004 | EP1409748A2 Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
| 04/21/2004 | EP1409740A2 Asthma-associated gene |
| 04/21/2004 | EP1409725A2 Diagnosis and treatment of blood disorders |
| 04/21/2004 | EP1409715A2 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 04/21/2004 | EP1409711A2 Compositions and methods for increasing amino acid absorption in mammals |
| 04/21/2004 | EP1409710A1 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 04/21/2004 | EP1409709A2 A method for improving recombinant protein stability and solubility |
| 04/21/2004 | EP1409699A1 Recombinant vectors derived from adeno-associated virus expressing tam67 for gene therapy |
| 04/21/2004 | EP1409696A2 Identification and characterization of plant genes |
| 04/21/2004 | EP1409694A1 Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
| 04/21/2004 | EP1409692A1 Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine |
| 04/21/2004 | EP1409684A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 04/21/2004 | EP1409683A2 i HELICOBACTER /i PROTEINS, NUCLEIC ACIDS AND USES THEREOF |
| 04/21/2004 | EP1409682A2 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes |
| 04/21/2004 | EP1409681A2 Proteins and nucleic acids encoding same |
| 04/21/2004 | EP1409680A2 Novel human proton-gated channels |
| 04/21/2004 | EP1409679A2 Nov-x proteins and nucleic acids encoding same |
| 04/21/2004 | EP1409678A2 Zis-sr nucleic acid and amino acid sequences involved in the regulated secretory pathway and/or the regulation of the neuroendocrine phenotype (nep) |
| 04/21/2004 | EP1409677A2 Receptors and membrane-associated proteins |
| 04/21/2004 | EP1409676A2 Cd109 nucleic acid molecules polypeptides and methods of use |
| 04/21/2004 | EP1409675A1 Gene involved in apoptosis regulation |
| 04/21/2004 | EP1409674A2 Human 7tm proteins and polynucleotides encoding them |
| 04/21/2004 | EP1409673A2 Human leucine-rich repeat containing protein, expressed predominantely in small intestine, hlrrsi1 |
| 04/21/2004 | EP1409660A2 Crystal structure of beta-site app cleaving enzyme (bace) and use thereof |
| 04/21/2004 | EP1409655A2 Immunoglobulin superfamily proteins |
| 04/21/2004 | EP1409653A1 Viral mutants that selectively replicate in targeted human cancer cells |
| 04/21/2004 | EP1409652A2 Immortalized preosteoblasts and method for their production |
| 04/21/2004 | EP1409646A2 Transgenic animals comprising a humanized immune system |
| 04/21/2004 | EP1409638A2 Cell cycle nucleic acids, polypeptides and uses thereof |
| 04/21/2004 | EP1409552A2 Fusion proteins, method for the production and use thereof |
| 04/21/2004 | EP1409551A2 Chimeric capsid proteins and uses thereof |
| 04/21/2004 | EP1409550A1 Extracellular messengers |
| 04/21/2004 | EP1409547A2 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| 04/21/2004 | EP1409546A2 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 04/21/2004 | EP1409545A2 Allelic variants of grp50 |
| 04/21/2004 | EP1409543A2 Isolated human receptor proteins, nucleic acid molecules encoding human receptors proteins, and uses thereof |
| 04/21/2004 | EP1409542A2 Blood group antigen fusion polypeptides and methods of use thereof |
| 04/21/2004 | EP1409540A2 Melanocortin receptor ligands |
| 04/21/2004 | EP1409539A1 Method for obtaining a tgf-beta enriched protein fraction in activated form, protein fraction and therapeutic applications |
| 04/21/2004 | EP1409538A1 Process for obtaining growth factor (tgf-beta and igf-1), lactoperoxidase and immunoglobulins preparations from milk products having low mutual cross-contamination |
| 04/21/2004 | EP1409537A2 Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques |
| 04/21/2004 | EP1409536A2 Human proteins and nucleic acids encoding same |
| 04/21/2004 | EP1409535A2 Human secreted proteins |
| 04/21/2004 | EP1409534A2 Pharmaceutical composition for treating and preventing human tumors, which express the tumor antigen mucin and/or the carcinoembryonic antigen (cea), and the use thereof |
| 04/21/2004 | EP1409533A2 Recombinant plasmodium falciparum merozoite protein-1/42 vaccine |
| 04/21/2004 | EP1409532A2 Moringa seed proteins |
| 04/21/2004 | EP1409531A2 Heterocarpine, a human ghrh-binding protein |
| 04/21/2004 | EP1409528A2 Novel compounds |